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Abstract
The Varicella Zoster Virus (VZV) is a ubiquitous human alpha-herpesvirus that is the causative agent of chicken pox and
shingles. Although an attenuated VZV vaccine (v-Oka) has been widely used in children in the United States, chicken pox
outbreaks are still seen, and the shingles vaccine only reduces the risk of shingles by 50%. Therefore, VZV still remains an
important public health concern. Knowledge of VZV replication and pathogenesis remains limited due to its highly cell-
associated nature in cultured cells, the difficulty of generating recombinant viruses, and VZV’s almost exclusive tropism for
human cells and tissues. In order to circumvent these hurdles, we cloned the entire VZV (p-Oka) genome into a bacterial
artificial chromosome that included a dual-reporter system (GFP and luciferase reporter genes). We used PCR-based
mutagenesis and the homologous recombination system in the E. coli to individually delete each of the genome’s 70 unique
ORFs. The collection of viral mutants obtained was systematically examined both in MeWo cells and in cultured human fetal
skin organ samples. We use our genome-wide deletion library to provide novel functional annotations to 51% of the VZV
proteome. We found 44 out of 70 VZV ORFs to be essential for viral replication. Among the 26 non-essential ORF deletion
mutants, eight have discernable growth defects in MeWo. Interestingly, four ORFs were found to be required for viral
replication in skin organ cultures, but not in MeWo cells, suggesting their potential roles as skin tropism factors. One of the
genes (ORF7) has never been described as a skin tropic factor. The global profiling of the VZV genome gives further insights
into the replication and pathogenesis of this virus, which can lead to improved prevention and therapy of chicken pox and
shingles.
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Introduction
Human varicella-zoster virus (VZV) is a widespread human alpha-
herpesvirus, and the majority of the US population has been
previously exposed [1]. VZV is the causative agent of chicken pox
and shingles, the latter of which is associated with a significant
incidence of post-herpetic neuralgia [2,3]. A universal chicken pox
vaccine (v-Oka strain) was first introduced to the United States in
1995, and this immunization program has dramatically reduced
chicken pox incidence [4–10]. However, outbreaks of chicken pox
are still seen [11–13], and shingles remains an important concern
because the current shingles vaccine only reduces the risk of infection
by about 50% [14]. Therefore, VZV is still an important pathogen
and remains a public health concern in the U.S. [7,15]. A better
understanding of the biology and pathogenesis of VZV is essential to
improvethemedicalpreventionandthetreatmentofVZVinfections.
VZV is the smallest member of the human herpesvirus family,
with a linear double-stranded DNA genome (125 kb) that encodes
70 unique ORFs. As a result of the recent development of a VZV
cosmid system and of the severe combined immunodeficient
mouse model with xenografts of human tissue (SCID-hu), many
viral ORFs have been investigated in both biochemical and
functional studies, shedding light upon several VZV gene functions
[16–18]. However, the majority of VZV’s 70 unique ORFs have
not been studied, and their roles in viral replication and cell-/
tissue-specific pathogenesis remain unclear. This is partly due to
the absence of an efficient genetic tool to quickly isolate a large
number of mutants and a true animal model to screen for in vivo
virulence factors on a large scale [2]. Though the functions of
many ORFs can only be predicted based on their homologies to
other herpesviruses, such as herpes simplex virus 1, our direct
manipulation of VZV’s ORFs has enabled us to provide functional
annotations for the entire VZV genome.
The knowledge of VZV replication and pathogenesis is limited,
in part because of its highly cell-associated nature in cultured cells
and the difficulty of generating recombinant viruses. In order to
circumvent some of these problems, we cloned the VZV (p-Oka
strain) genome as a bacterial artificial chromosome (BAC) carrying
both green fluorescent protein (GFP) and luciferase reporter genes
[19]. We then systematically deleted every open reading frame in
the VZV genome. An overview of our method for genome-wide
mutagenesis is shown in Figure 1. With a highly efficient
homologous recombination system and the dual-reporter system,
the recombinant viruses were isolated and analyzed.
PLoS Pathogens | www.plospathogens.org 1 July 2010 | Volume 6 | Issue 7 | e1000971Human fetal skin organ culture (SOC) has been previously
established to mimic VZV skin infection, which allows for the
study of VZV replication and pathogenesis [20]. We further
combined SOC with the luciferase assay-based viral detection
method to facilitate screening of skin tropism determinants.
Although many investigators utilize SCID-hu models (grafts of
human tissue in severe combined immunodeficient mice) to study
VZV pathogenesis in vivo [21], SOC is a more suitable and cost
efficient approach for genome-wide screening the VZV mutant
phenotypes. Nevertheless, any interesting findings can be further
verified by further in-depth SCID-hu model studies.
The luciferase VZV BAC (VZVLuc) was used to individually
delete and/or mutate each of the 70 unique ORFs by employing
the E. coli DY380 strain recombination system [22]. As a result, a
library of whole-ORF deletion mutants was created. Each mutant
DNA obtained from E. coli was transfected into human melanoma
(MeWo) cells, and the results provide direct evidence of that 44
ORFs are essential for viral replication in cultured MeWo cells
and 26 are non-essential. Moreover, among the non-essential gene
group, 8 ORF deletion mutants showed significant growth defects
compared to the wild-type strain (p-value ,6.07610
221; see
‘‘Statistical Analysis of Mutant Growth Kinetics’’ section in
Figure 1. Generation of VZV deletion and rescue clones. A. Generation of the ORFX deletion mutant clone. 1. The E. coli DY380 strain provides
a highly efficient homologous recombination system, which allows recombination of homologous sequences as short as 40bp. The homologous
recombination system is strictly regulated by a temperature-sensitive repressor, which permits transient switching-on by incubation at 42uC for
15min. VZVluc BAC DNA is introduced into DY380 by electroporation. Electro-competent cells are prepared with homologous recombination system
activation. 2. Amplification of the kan
R expression cassette by PCR using a primer pair adding 40-bp homologies flanking ORFX. 3. About 200ng of
above PCR product are transformed into DY380 carrying the VZVluc BAC via electroporation. 4 and 5. Homologous recombination between upstream
and downstream homologies of ORFX replaces ORFX with the Kan
R cassette, creating the ORFX deletion VZV clone. The recombinants are selected on
LB agar plates containing kanamycin at 32uC. 6. The deletion of ORFX DNA is isolated and confirmed by testing antibiotic sensitivity and PCR analysis.
The integrity of the viral genome after homologous recombination is examined by restriction enzyme digestion. 7. Purified BAC DNA is transfected
into MeWo cells. 8. 3–5 days after transfection the infected cells are visualized by fluorescence microscopy. B. Generation of ORFX rescue virus. 1. To
generate the ORFX clone, ORFX was amplified by PCR from the wild-type VZV BAC DNA. 2. ORFX was directionally cloned into plasmid pGEM-lox-zeo
to form pGEM-zeo-ORFX. 3. Amplfication of the ORFX-Zeo
R cassette by PCR using a primer pair adding 40 bp homologies flanking ORFX. 4. The PCR
product was transformed into DY380 carrying the VZVLuc ORFX deletion via electroporation. 5 and 6. Homologous recombination between upstream
and downstream homologies of ORFX replaced Kan
R with the ORFX-Zeo
R cassette, creating the ORFX rescue clone. 7. Zeo
R and BAC vector sequences
were removed while generating virus from BAC DNA (by co-transfecting a Cre recombinase-expressing plasmid).
doi:10.1371/journal.ppat.1000971.g001
Author Summary
The Varicella Zoster Virus (VZV) is the causative agent of
chicken pox and shingles. The long-term efficacy of the
current chickenpox vaccine is yet to be determined, and
the current shingles vaccine fails to provide protective
immunity for a substantial number of individuals. Shingles
can also lead to post-herpetic neuralgia (PHN), a debilitat-
ing condition associated with an intractable pain that can
linger for life. Therefore, VZV remains an important public
health concern. We use growth-rate analysis of our
genome-wide deletion library to determine the essentiality
of all known VZV genes, including novel annotations for
51% of the VZV proteome. We also discovered a novel
skin-tropic factor encoded by ORF7. Overall, our identifi-
cation of genes essential for VZV replication and patho-
genesis will serve as the basis for multiple in-depth genetic
studies of VZV, which can lead to improved prevention
and therapy of chicken pox and shingles. For example,
essential genes may be appealing drug targets and genes
whose deletion causes a substantial growth defect may be
prospective candidates for novel live attenuated vaccines.
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non-essential ORF deletion mutant VZV variants obtained have
been tested in SOC. Interestingly, four ORFs were found to be
required for optimal viral replication in cultured skin tissue
samples, but not in MeWo cells, suggesting their potential roles as
skin tropism factors. The results obtained from this study are in
agreement with most of those regarding these particular ORFs
that have been published to date, and we have provided
explanations of all possible discrepancies in the literature. Overall,
we provide 51% novel functional annotations to the VZV
proteome (36 ORFs).
Results
Generation of VZV ORF deletion and rescue mutants
All VZV ORF deletion mutants were constructed from BAC
mutants with a luciferase reporter (VZVLuc) using a PCR-based
approach [19,22] (also see Supplementary Text S1). Construction
of ORF rescued BAC mutants was carried out by adapting a two-
step homologous recombination approach in E. coli [19,22] (also
see Supplementary Text S1). The generation of a rescue virus is
important in order to prove that the deleted fragment was
responsible for any growth defect observed in analyses of the
mutants. The rescue virus should be able to fully restore the wild-
type phenotypes. Because of the large number of ORFs, we chose
a small subset of VZV open reading frames to rescure and we have
shown these rescue mutants behave as the wild –type strain. A
detailed description of these protocols is provided in [19,22] and
an overview is shown in Figure 1. Previous studies in our
laboratory have shown that the BAC mutant has an identical
growth curve to the wild-type virus [19] and that addition of the
luciferase reporter to the BAC virus does not change its growth
properties [22].
Identification of essential VZV genes
All of VZV’s 70 unique ORFs were deleted and analyzed based
on a bioluminescence detection method, as described previously
[19]. For 14 ORFs that overlap with adjacent ORFs (ORF8,
ORF9A, ORF25, ORF26, ORF27, ORF28, ORF46, ORF47,
ORF48, ORF49, ORF50, ORF54, ORF59 and ORF60),
respective partial ORF deletions have been constructed and
analyzed. A detailed description of these partial ORFs is included
in Supplementary Table S2. The results suggest that 44 ORFs are
essential for viral replication in cultured MeWo cells (Table 1 and
Figure 2). We have confirmed that ORF4 and ORF5 are essential
by making genetic rescue viruses. For the essential group, we
provide novel functional annotations for 31 of 44 ORFs. All of
these VZV essential genes have HSV-1 homologies (Table 1), and
the majority of them are conserved among other herpesviruses.
These ORFs encode important viral structural proteins, enzymes
involved in DNA replication, and transcriptional regulatory
proteins.
Among VZV’s 44 essential ORFs, the majority encodes proteins
with vital functions throughout the viral life cycle. Most VZV
proteins that regulate transcription (ORF4, ORF62/71, ORF63/
70, and ORF 61) were found to be essential in this study. ORF4
and ORF62/71 are incorporated into the viral tegument, and
both encode immediate-early (IE) proteins with transcriptional
regulatory activity [23–26]. ORF4 and ORF62/71 have been
extensively studied, and their essential natures have been suggested
previously [27,28]. Both ORF63/70 and ORF61 encode phos-
phoproteins primarily localized to the nuclei of infected cells [25].
Although it has been suggested that ORF 63/70 is not essential for
viral replication in vitro [29], we could not generate a viable virus
from a 63/70 double deletion; this result is in agreement with
several other studies [30,31].
Most of the VZV ORFs that encode glycoproteins are essential.
Glycoprotein K (gK) (encoded by ORF5) [32], gB (ORF31), gH
(ORF37), gM (ORF50) [33], gL (ORF60) [34,35], and gE
(ORF68) [32,36] are required for viral replication, and many of
them had previously been investigated and reported. Only
glycoprotein C (ORF14) [37,38] and gI (ORF67) [36,39,40]
deletion mutants produced viable viral progenies, and both of
these mutants appeared to suffer a severe growth defect. The
results regarding the essentiality of VZV glycoprotein genes in this
study are in agreement with the published data.
Essential VZV genes have significantly different enrichment for
functional categories than do non-essential genes (Figure 3A). In
order to make this calculation, we first listed every gene in a
functional category, such as ‘‘DNA replication’’ for a DNA
polymerase gene. Then, we compared the proportion of essential
(and then of non-essential) genes in each functional category to the
background rate expected by chance (e.g. the proportion of genes
in that functional category for the entire VZV genome). This
calculation was performed using a hypergeometric test. For
example, essential genes are significantly enriched for DNA
replication (Bonferroni corrected p-value ,10
24) and for DNA
packaging (Bonferroni corrected p-value ,10
24); ORF28 encodes
the catalytic subunit of VZV DNA polymerase and ORF16
encodes the subunit of the viral DNA polymerase processivity
factor [2]. DNA binding proteins include proteins encoded by
ORF6 (primase), ORF29, ORF33 (capsid protein), ORF41 (capsid
protein), ORF51 (helicase), ORF52 (component of helicase/
primase complex), and ORF55 (component of helicase/primase
complex) [41,42]. Not surprisingly, almost all of the ORFs that
encode DNA packaging proteins—including ORF25, ORF26,
ORF30, ORF34, ORF42/45, ORF43, ORF54, and nucleocapsid
proteins including ORF21, ORF33.5, and ORF40—also fall into
the essential gene category. In contrast, non-essential genes were
significantly enriched for other (Bonferroni corrected p-value
,10
23) and unknown (Bonferroni corrected p-value ,0.01)
functional categories (Figure 3B).
Identification of non-essential genes
In this study, we found that 26 ORFs are non-essential genes
and 6 of these lack HSV-1 homologies (ORF0, ORF1, ORF2,
ORF13, ORF32, and ORF57) (Table 1). According to the growth
kinetics (in cultured MeWo cells), 8 ORF mutants had significant
growth defects (p-value ,6.07610
221), and the peak signals of the
viral detection assay were at least 5-fold less than were those of the
wild-type parental strain (Figure 4A). Two of these VZV ORF
deletion growth phenotypes, ORF18 and ORF32, have not been
previously reported, and two others (ORF23 and ORF35
deletions) have been confirmed to have growth defects in vitro,
which is in accordance with previously published data [43,44].
ORF0 deletion’s growth defect has been confirmed by making its
genetic revertant [19]. ORF18 and ORF19 respectively encode
the small and large subunits of ribonucleotide reductase, and both
of them diminished viral growth when deleted in this study. The
result on ORF19 is in accordance with previous publications [45].
ORF32 encodes a phosphoprotein that is post-translationally
modified by ORF47 protein kinase [46]. Among these 8 viral
mutants showing severe growth defects, atypical morphology of
virally infected cells was frequently observed, including reduced
plaque sizes and altered syncytia formation.
The remaining 18 VZV ORFs had wild type growth curves for
viral replication in cultured MeWo cells. In vitro growth curve
analysis showed that these ORF deletion mutants had the same
Genome-Wide Mutagenesis Reveals a VZV Skin-Tropic Factor
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(Table 1). Previous studies have reported that 15 of these genes
(ORF1, ORF2, ORF3, ORF8, ORF10, ORF11, ORF12,
ORF13, ORF14, ORF47, ORF57, ORF59, ORF58, ORF64/
69, and ORF65) are non-essential [17,31,38,46–54]. In this study,
three of these ORF mutants (ORF7, ORF15, and ORF36) have
been shown to be dispensable for in vitro viral replication for the
first time.
The human fetal skin organ culture (SOC) model has been
proven to be a simple and convenient alternative to the SCID-hu
mouse model in the study of VZV pathogenesis [20], especially in
the case of an initial genome-wide screening for skin tropism
determinants. Although 26 VZV ORFs were found to be non-
essential for viral replication in cultured MeWo cells, it was
possible that some of these viral genes encode proteins critical for
optimal viral infection in skin tissue. To test this hypothesis, all 26
Table 1. A list of VZV pOka strain ORFs categorized by the growth properties of their respective deletion mutants in MeWo cells
and human fetal skin organ cultures (SOC).
ORF Function
HSV-1
Homology ORF Function
HSV-1
Homology
No growth (44 mutants; Essential in MeWo) No growth (continued)
ORF4
R Transcriptional regulator UL54 ORF56
S, 1 Unknown UL4
ORF5
R Glycoprotein gK
3 UL53 ORF60
S Glycoprotein gL UL1
ORF6
1 Primase
3 UL52 ORF61
2 Transcriptional regulator ICP0
ORF9A
S, 2 Envelope glycoprotein protein gN
3 UL49A ORF62/71
D Transcriptional regulator ICP4
ORF9 Tegument pr with unknown function UL49 ORF63/70
D Host range factor; Tegument protein US1
ORF16
1 DNA polymerase
3 UL42 ORF66
2 Serine-threonine kinase US3
ORF17
2 Host shut-off factor UL41 ORF68 Glycoprotein gE US8
ORF20
1 Component of intercapsomeric triplex
3 UL38 Growth Defect (8 Mutants; Defect in MeWo and SOC)
ORF21 Nucleocapsid protein UL37 ORF0
R Putative transmembrane protein
3 None
ORF22
1 Tegument protein with unknown function
3 UL36 ORF18
1 Small subunit of ribonucleotide reductase UL40
ORF24
1 Phosphoprotein
3 UL34 ORF19 Large subunit of ribonucleotide reductase UL39
ORF25
S, 1 DNA packaging protein UL33 ORF23 Small capsid protein UL35
ORF26
S, 1 DNA packaging protein UL32 ORF32
1 Probable substrate for ORF47 kinase
3 None
ORF27
S, 1 Nuclear matrix protein
3 UL31 ORF35 Role in cell to cell fusion UL24
ORF28
S, 1 DNA polymerase catalytic subunit UL30 ORF49
S Role in virion envelopment UL11
ORF29 Single-stranded DNA-binding protein UL29 ORF67 Glycoprotein gI US7
ORF30
1 DNA packaging protein UL28 Skin-Tropic (4 mutants; Defect in SOC; WT in MeWo)
ORF31
1 Envelope glycoprotein gB UL27 ORF7
R, 1 Tegument protein with unknown function
3 UL51
ORF33
1 Major capsid scaffold protein UL26 ORF10
R Tegument protein; transactivator of IE genes UL48
ORF33.5
1 Minor capsid scaffold protein UL26.5 ORF14 Glycoprotein gC UL44
ORF34
1 DNA packaging protein UL25 ORF47
S Serine-threonine kinase UL13
ORF37
1 Glycoprotein gH UL22 Dispensable (14 mutants; WT growth in SOC and MeWo)
ORF38
1 Tegument protein with unknown function
3 UL21 ORF1 Transmembrane protein None
ORF39
1 Integral membrane protein
3 UL20 ORF2 Unknown None
ORF40
1 Component of hexons and pentons UL19 ORF3 Unknown UL55
ORF41
1 Minor capsid protein
3 UL18 ORF8
S Deoxyuridine triphosphatase UL50
ORF42/45
1 DNA packaging protein UL15 ORF11 Tegument protein with unknown function
3 UL47
ORF43
1 DNA packaging protein UL17 ORF12 Tegument protein with unknown function
3 UL46
ORF44
1 Tegument pr with unknown function
3 UL16 ORF13 Thymidylate synthase None
ORF46
S, 1 Tegument pr with unknown function
3 UL14 ORF15
1 Integral membrane protein
3 UL43
ORF48
S, 1 Deoxyribonuclease
3 UL12 ORF36
1 Deoxypyrimidine kinase UL23
ORF50
S, 1 Glycoprotein gM
3 UL10 ORF57 Tegument protein; role in virion egress
3 None
ORF51
1,4 Origin binding pr/helicase UL9 ORF58 Unknown UL3
ORF52
1 Component of helicase-primase complex
3 UL8 ORF59
S Uracil-DNA glycosylase UL2
ORF53
1,4 Tegument protein with unknown function
3 UL7 ORF64/69
D Tegument pr with unknown function
3 US10
ORF54
S, 1 DNA packaging protein UL6 ORF65 Virion protein involved in axonal transport US9
ORF55,
1 Helicase
3 UL5 Essential
Superscript Annotations: ‘‘1’’ corresponds to ‘‘results from this study only,’’ ‘‘2’’ corresponds to ‘‘results from this study not consistent with previous studies,’’ ‘‘3’’
corresponds to ‘‘putative function based on homology,’’ ‘‘4’’ corresponds to ‘‘phenotype may be due to effect from adjacent gene,’’ ‘‘S’’ corresponds to ‘‘partial ORF
deletion virus study included,’’ ‘‘D’’ corresponds to ‘‘double ORF deletion virus study included,’’ and ‘‘R’’ corresponds to ‘‘Rescue virus study included.’’
doi:10.1371/journal.ppat.1000971.t001
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cultured skin-tissue samples.
Every deletion mutant that showed severe growth defects in
cultured MeWo cells also demonstrated significantly slow growth
kinetics in human skin samples when compared to wild-type VZV
(p-value ,9.05610
219). Only two of these genes (ORF35 and
ORF67) have been previously reported to be required for viral
growth in SCID-hu skin mouse models [40,44]. Therefore, we
have been able to provide novel functional annotations for the
other 6 deletion mutants with severe growth defects.
Many non-essential genes appear to cluster together, particu-
larly between ORF0 to ORF15 (Figure 2). More than 70% of
ORFs (12 out of 17) in this region are non-essential, compared to
37% of the entire genome. Four out of six VZV ORFs without
HSV-1 homologues are also located in this region, so this region
may be more evolutionarily variable compared to other highly
conserved regions
Among the 18 VZV ORFs dispensable for viral replication in
cultured MeWo cells, 14 were also dispensable for viral replication
in skin tissue (Table 1). Among the above 14 deletion mutants, we
Figure 2. VZV genome-wide functional profiling based on analysis of viral mutants with single open reading frame deletion
mutants. Genomic organization and ORFs arrangement are based on the viral sequence of the VZV pOka strain. Each VZV ORF is color-coded
according to the growth properties of its corresponding virus gene-deletion mutant in cultured MeWo cells and human fetal skin organ cultures. The
grey lines for ORF42 represent a splicing junction. For all growth curves, wild-type infections served as positive controls and mock infections served as
negative controls.
doi:10.1371/journal.ppat.1000971.g002
Figure 3. Distribution of functional annotations for essential and non-essential genes. A. Distribution of functional annotations for
essential genes. Essential genes are significantly enriched for DNA replication (Bonferroni corrected p-value ,10
24) and DNA packing (corrected p-
value ,10
24) functional categories. B. Distribution of functional annotations for non-essential genes. Non-essential genes are significantly enriched
for other (corrected p-value ,10
23) and unknown (corrected p-value ,0.01) functional categories. Statistical significance was determined by a
hypergeometric test.
doi:10.1371/journal.ppat.1000971.g003
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all but one of these 18 genes (ORF64/69) [31].
Identification of skin-tropic genes
Interestingly, among non-essential VZV ORFs, four ORFs
(ORF7, ORF10, ORF14, and ORF47) appear to have selective
impacts on viral replication in skin tissue. The growth of each virus
in SOC was compared with its growth in cultured MeWo cells.
These ORF deletion mutants grew like the wild-type strain in vitro
(Figure 4B). In contrast, they showed significant growth defects in
skin organ cultures (p-value ,9.51610
219; Figure 4C). For
instance, the ORF10 deletion mutant had a growth defect in
SOC. The bioluminescence signal kept increasing during the
entire 7-day experiment period; the total photon count values
consistently remained approximately 10-fold less than those of the
wild-type strain. The ORF7 deletion mutant virus quickly reached
its growth peak around 3 days after inoculation, and then
bioluminescence steadily declined. To prove that the VZV ORF7
and ORF10 growth defects observed in cultured skin-tissue
samples were due to the functions of the deleted genes rather
than to undesirable mutations in other regions of the genome,
rescue viruses ORF7R and ORF10R were generated. The growth
curve analysis indicated that ORF7R and ORF10R viruses grew
in MeWo cells indistinguishably from wild-type VZV, as expected
(Figure 4B). In skin organ cultures, they were also able to fully
recover the growth defects of the corresponding deletion mutant
viruses and grew as well as the wild-type strain (Figure 4C). In
contrast, ORF47 deletion virus had a more severe growth defect,
approximately 80–100 fold (2 log) less than wild-type VZV. Our
results suggest these three ORFs are important for viral replication
in human skin tissue but not in cultured MeWo cells.
Three skin-tropic virulence factors (ORF10, ORF14, and
ORF47) have been previously identified. VZV ORF10 encodes
a tegument protein that enhances transactivation of VZV genes,
and it was shown to be dispensable for VZV replication in vitro
[47]. Recent studies showed that ORF10 protein is required for
efficient VZV virion assembly and is a specific determinant of
VZV virulence in SCID-hu skin xenografts but not in human T
cells in vivo [55,56]. ORF14 (gC) has been reported to have
reduced infectivity in an SCID-hu skin model [38]. VZV ORF47
encodes a serine/threonine protein kinase and was shown to be
dispensable for viral replication in cultured MeWo cells [48]. It has
been designated as a virulence factor for both skin tissue and T
cells in SCID-hu models [38]. The findings of these three skin-
tropic ORFs not only confirmed previous studies but also further
verified the similarity between SCID-skin and SOC systems.
In the current study, ORF7 has been identified as a novel skin-
tropic virulence factor. In order to confirm the accuracy of our
results, we also produced a premature stop-codon mutant
(ORF7S) by mutating the 5
th codon from TGT to the TGA stop
codon (see Table S1). Just like ORF7D, ORF7S showed wild-type
growth in MeWo (Figure 4B) but had a growth defect in SOC
(Figure 4C).
Discussion
In this study, a global functional analysis of the entire VZV
genome was performed that emphasized the identification of viral
ORFs important for viral replication both in cultured MeWo cells
and human fetal skin organs. We took full advantage of the highly
efficient luciferase VZV BAC system and obtained a library of
single ORF deletion mutants. Advanced live culture biolumines-
cence imaging technology allowed us to systematically test a large
number of mutant viruses for comparing viral growth kinetics in
different systems.
VZV has a 125-kb DNA genome encoding 70 unique open
reading frames (Table 1, Figure 2). In this study, all of the
predicted 70 ORFs were individually deleted. Our results directly
showed that 44 ORFs encode essential genes and 26 ORFs encode
non-essential genes. Among the non-essential group, 8 ORF
deletion mutants suffered severe growth defects in MeWo cells.
Fourteen ORFs were shown to be dispensable for viral replication,
both in MeWo cells and in SOC. We also found 4 tissue tropic
factors (ORF7, ORF10, ORF14, and ORF47) that showed a
growth defect in SOC but normal growth in MeWo. Three of
these tissue-tropic factors (ORF10, ORF14, and ORF47) have
been previously identified, but ORF7 has never been previously
studied.
In the current study, we have reported ORF7 as a novel VZV
skin-tropic factor. ORF7 encodes a 29-kDa tegument protein, and
its function remains unknown. The homolog of the VZV ORF7
protein in the herpes simplex virus is the UL51 protein. Recent
Figure 4. Growth curve analysis of some VZV deletion mutants. A. Eight VZV ORF deletion mutants showing slow growth kinetics in cultured
MeWo cells. One hundred PFU of each deletion mutant and VZVLuc (WT) were infected with MeWo cells in 6-well dishes in triplicate. Bioluminescence
was measured using the IVIS system every day for 7 days after D-luciferin was applied to the cultured media. Total Photon Count in each well
(photons/sec/cm
2/steradian) was measured, and the values from the triplicate results were averaged. The growth curves were generated when
averaged photon counts for each day were plotted. Error bars represent standard deviation for three replicates. B. In vitro growth curve analysis of
VZV ORF7, ORF10, and ORF47 mutant viruses. One hundred PFU of ORF7 and ORF10 mutant and rescue (ORF7D, ORF7S, ORF7R, ORF10D, and
ORF10R) and ORF47 deletion virus (ORF47D) from infected MeWo cells were used to infect 50% confluent MeWos seeded in 6-well dishes.
Experiments were performed in triplicates. The growth curves were generated as described in A. C. Growth curve analysis of VZV ORF7, ORF10, and
ORF47 mutants in human fetal skin organ cultures. Skin tissues were inoculated with 5610
3 PFU VZVLuc or other VZV variants, as indicated. VZV
replication was monitored daily by IVIS for one week as bioluminescence emitting from each skin culture was measured. Each line represents an
average of the data from 3 different skin tissue samples, all infected with the same virus. D-luciferin was also applied to three uninfected skin tissue
samples (injected with PBS) as mock infection.
doi:10.1371/journal.ppat.1000971.g004
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plaque formation and low infectivity [56]. Similarly, the function of
the UL51 gene product of the pseudorabies virus (PrV) has been
investigated by generating a deletion mutant, and the result
suggested that the UL51 protein is involved in viral egress, but is
not essential for viral replication [57]. Our result suggests that VZV
ORF7 might serve as a skin-specific virulence factor. However, the
role of ORF7 in pathogenesis needs further investigation.
Despite the large differences between herpesvirus genomes
(ranging from 125 kb to .230 kb), all the herpes viruses studied
thus far have a similar number of essential genes. For example,
HSV-1 encodes 37 essential genes and 48 non-essential genes [58];
human cytomegalovirus (HCMV), which is one of the largest
human DNA viruses, encodes 45 essential genes and 117 non-
essential genes [59]. Our data suggest that VZV, which contains
the smallest genome, encodes 44 essential genes and 26 non-
essential genes. A comparison between the essentiality of HSV-1
and HCMV homologues to essential VZV genes is provided in
Supplementary Table S3. Of the 44 essential genes, 26 have
essential homologues in HSV, and all essential gene homologues
conserved in CMV (18 of 44 essential VZV genes) are essential.
Therefore, we believe that several of these essential genes perform
core functions for all of these herpesviruses.
Unlike the other functional profiling studies performed on
HCMV [59], our results did not reveal any VZV-encoded factors
that repress viral replication in cultured MeWo cells or in human
fetal skin tissue. If such VZV temperance genes existed, enhanced
growth kinetics should have been observed by making the
corresponding ORF deletion mutants.
There is also an apparent size difference between essential and
non-essential ORFs. Essential ORFs are significantly larger in size
compared to non-essential ones (m=1250 bp vs. m=970 bp,
respectively, p=6610
24 by t-test). The 10 largest VZV ORFs are
all essential, while 8 out of 11 VZV ORFs less than 600 bp are
non-essential.
All of our results are in agreement with previous VZV
functional annotations, except for those on ORFs 9A, 17, 61
and 66, for which we could not generate viral deletion mutant
progenies with sufficient titers for growth studies. For example,
previous studies indicated that was ORF9A not essential viral
growth in cell culture (due to insertion of a premature stop codon)
yet they also showed that failure to express either of these genes
resulted in growth defects [60]. Therefore, we believe that our
findings are at least in partial agreement with previous studies
because this previous study utilized a premature stop codon (thus
allowing expression of a partial protein), whereas we completely
removed ORF9A from the VZV genome.
Although some studies have shown ORF17 to be dispensable
for viral replication [61], other studies have shown the gene to be
essential for growth under certain conditions [62]. Therefore, we
believe this discrepancy can probably be explained by subtle
differences in experimental design (such as the temperature of the
growth culture, as described in [62], and we believe that our
analysis for ORF17 deletion best reflects conditions in vivo.
ORF61 has also been suggested to be a non-essential gene for
viral replication in vitro in a previous study [63,64]. However, we
could not retrieve enough infectious viral progeny from the
ORF61 deletion clone, even after repeated transfection and
extensive incubation. Large deletion mutants of ORF61 [63] and
promoter bashing experiments [64] have shown ORF61 to be
important for viral replication (albeit non-essential) due to a
considerable growth defect shown in the deletion. However, no
complete deletion virus has ever been created, so it is possible that
the large deletions may have only been sufficient to cause a growth
defect, whereas our complete deletion results in a complete loss of
VZV replication.
ORF66 has been previously cited as dispensable for viral
replication, but we have found it to be essential [65–67]. In
previousstudies, a premature stopcodon mutant of ORF66resulted
in a decrease in viral titer, but not in a complete loss of viral
replication [65,66]. Premature stop codons were inserted such that
more than 50% of the original coding sequence remained and was
able to beexpressed,sowebelieve thisdiscrepancy canbe explained
by the possible attenuated activity of the partial protein (which did
have a substantial growth defect), while our ORF66 deletion
removed the entire sequence. For the cosmid-based studies [67,68],
a premature stop codon mutant (with a 21-amino acid partial
protein expressed) had to be used to assess the impact of ORF66 on
viral replication. However, the authors [68] were also unable to
produce infectious virus with a complete ORF66 deletion mutant
(which is identical to our results).
In this study, we have presented novel functional annotations
for 36 VZV genes. Due to the global nature of our study and the
lack of well-defined upstream and downstream regulatory regions
for most VZV genes, some of our annotations may have to be
redefined by more detailed studies (genes most likely to be affected
by adjacent genes are specifically noted in Table 1). Moreover, the
current profiling study has provided the first global view of VZV
genomic functions in viral replication, which is likely to serve as
the basis for further investigative studies on many VZV genes.
Materials and Methods
Cells, virus and PCR primers
Human melanoma (MeWo) cells were grown in DMEM
supplemented with 10% fetal calf serum, 100U of penicillin-
streptomycin/ml, and 2.5ug of amphotericin B/ml, as previously
described, and used to propagate VZV in vitro [18,69]. VZVLuc
containing the entire p-Oka VZV genome was constructed as
previously described [19]. Recombinant VZVLuc virus was derived
by transfection methods [19,22] (also see Supplementary Text S1).
All primer sequences are listed in Supplementary Table S1.
Primer sequences were designed based upon the Dumas VZV
strain (Accession Number: NC_001348).
Growth analysis of viral mutants in vitro
VZVLuc DNAs were transfected into MeWo cells using the
FuGene 6 transfection kit (Roche, Indianapolis, IN) [19,22] (also
see Supplementary Text S1). Recombinant viruses were titrated by
infectious focus assay. MeWo cells were seeded in 6-well tissue
culture plates and inoculated with serial dilutions of VZV-infected
MeWo cell suspensions. Plaques were counted by fluorescence
microscopy at 3 days after inoculation. All transfections were
performed a minimum of 3 times. Since VZV is highly cell-
associated under tissue culture conditions, mutant VZV-infected
MeWo cells were harvested, titrated and stored in liquid nitrogen.
Wild-type infections served as positive controls and mock
infections served as negative controls.
In vitro growth curve analyses were carried out by live-cell
bioluminescence detection assay. MeWo cells were infected with
100 PFU of infected MeWo cell suspensions on 6-well tissue
culture plates. Every 24 h, the cell culture medium was replaced
with medium containing 150 ug/ml D-luciferin (Xenogen,
Alameda, CA). After incubation at 37uC for 10 min, the
bioluminescent signals were quantified and recorded using an
IVIS Imaging System (Xenogen), following the manufacturer’s
instructions. After each measurement, the luciferin-containing
medium was replaced with fresh cell culture medium. Measure-
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Bioluminescence signal data from each sample were quantified
by manually demarcating regions of interest and analyzed using
LivingImage analysis software (Xenogen). It has been demonstrat-
ed previously that both the infectious center assay and the
luciferase assay correlate well [19,22].
Growth analysis of viral mutants in SOC
Human fetal skin-tissue samples (,20 weeks gestational age)
were acquired from Advance Biosciences Resources (Alameda,
CA). Skin organ-culture techniques were as previously described
[20]. Ex vivo growth curve analyses were carried out by live-tissue
bioluminescence assay. Infected MeWo cells were titrated and
then re-suspended in skin organ culture media (SOCM). After
24 h of incubation, each skin-tissue section was injected five times
with 10 ul of the virus-infected cell suspension (total inoculation
was 5610
3 PFU per tissue) by a 1-ml syringe fitted with a 27-gauge
needle attached to a volumetric stepper (Tridak, Brookfield, CT).
After inoculation, the sections were placed individually on 500 um
mesh NetWell inserts (Corning, Corning, NY) that rested above
1ml of SOCM in each well of 12-well plates and followed by a
24 h incubation in a tissue culture incubator, 37uC, 5%CO2. Each
24 h, SOCM was replaced with media containing 150ug/ml of D-
luciferin. Following 10 min incubation at 37uC, the biolumines-
cence being emitted from individual cultured skin-tissue samples
was recorded using the IVIS Imaging System. After the
measurements, each sample (still on a NetWell insert) was
transferred onto new 12-well plates with fresh SOCM. The
measuring process was repeated every 24 h for 7 days.
Bioluminescence signals from manually defined regions of interest
were quantified and analyzed. All experiments were performed in
triplicate. Wild-type infections served as positive controls and
mock infections served as negative controls.
Statistical analysis of mutant growth kinetics
Wild type and mutant growth curves (7 time points, 3 replicates
each) were compared using the ‘‘timecourse’’ Bioconductor
package [70,71]. The difference in growth rate for wild type and
mutant growth curves was estimated by the mb.long function was
used to estimate a Hotelling T
2 test statistic using the mb.long
function. P-values for the T
2 test statistic were calculated using an
F-distribution. The T
2 test statistic did an excellent job of
quantifying the difference in growth curves, but a very strict p-
value cutoff was required in order to define statistically significant
growth defects (implying that the test statistic may be too sensitive).
Therefore, we used a Mann-Whitney U test in order to determine
which individual time points significantly differed between wild
type and deletion mutant strains. All strains with reported growth
defects have at least 6 significantly reduced time points (p,0.05).
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